+91-8668442535

Percutaneous Coronary Intervention (PCI) Devices Market By Device Type (Coronary Stents, PTCA Catheters, Coronary Guidewires), By End-User (Hospitals, Ambulatory Surgical Centers (ASCs), Catheterization Labs) – Growth, Future Prospects and Competitive Analysis, 2018 – 2026

Percutaneous coronary intervention (PCI) is a non-surgical procedure utilized to treat coronary artery disease. A balloon catheter and coronary stents are used to remove the plaque and treat the narrowing of blood vessels. In a PCI procedure, a coronary guidewire is used to direct the balloon catheter to the site of the plaque in the coronary artery. A balloon catheter is thereafter inserted into the coronary artery of the heart and inflated at the site of the plaque. Generally, a stent is placed at that site to mitigate the risk of restenosis at the treatment site. The global percutaneous coronary intervention devices market is expected to grow in the forecast period owing to the rise in the incidence of heart diseases, diabetes, and coronary artery disease. Further development of advanced technologies for PCI procedures leads to the growth of the market.

This report studies the market for various devices used in PCI procedures and consists of the latest analysis of the global percutaneous coronary intervention devices market through extensive primary and secondary research. A comprehensive understanding of the global market is provided in the report based on quantitative and qualitative research. This report aids the market stakeholders in taking informed initiatives in the global percutaneous coronary intervention devices market.

For the analysis, the global percutaneous coronary intervention devices market is categorized based on device type, usage areas, and geographical demarcation. On the basis of device type, the global percutaneous coronary intervention devices market is categorized into coronary stents, PTCA catheters, and coronary guidewires. On the basis of usage areas, the global percutaneous coronary intervention devices market is categorized into hospitals, ambulatory surgical centers, and catheterization labs. The analysis of the global market for percutaneous coronary intervention devices is performed in terms of market size for the period 2016–2026, considering 2017 as the base year and 2018–2026 as the forecast period. The CAGRs of each of the aforementioned segments are calculated for the forecast period.

Based on geographical demarcation, the global percutaneous coronary intervention devices market is analyzed by categorizing the market into five major regions as follows:

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • United Kingdom
  • Rest of Europe
  • Asia-Pacific (APAC)
  • Japan
  • China
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • rest of Latin America
  • Middle East and Africa (MEA)
  • Gulf Cooperation Council (GCC)
  • Rest of the Middle East and Africa

On the basis of geographical demarcation, the market size of the global percutaneous coronary intervention devices market is presented for the period 2016–2026, and CAGRs are calculated for the forecast period. Further, geographical regions are analyzed by sub-segmenting them in terms of device type, end-user, and constituent countries.

Major qualitative market assessment factors are incorporated in the report, including key market insights, market trends and dynamics, product launches, and opportunities. The competitive landscape of major players is provided in a graphical format based on market share, product portfolio, and improvement opportunities. This report also constitutes Porter’s five forces model for the proper understanding of the global percutaneous coronary intervention devices market. Major players profiled in this report include Abbott Laboratories, Inc., Boston Scientific Corporation, Biotronik SE & Co. KG, B. Braun Melsungen AG, Biosensors International Group, Getinge AB, Johnson & Johnson, Medtronic plc, St. Jude Medical, and Terumo Corporation.

For the purpose of this study, the global market for percutaneous coronary intervention devices is studied by the following device types:

  • Coronary Stents
  • PTCA Catheters
  • Coronary Guidewires

A percutaneous coronary intervention procedure is performed to treat coronary artery disease by removing the plaque from the coronary arteries. Coronary guidewires are used to direct the PTCA catheters to the site of the plaque, and thereafter, catheters are employed for plaque removal. This is followed by stent placement at the site of the plaque to prevent restenosis.

In terms of market value, the PTCA catheter segment leads the global percutaneous coronary intervention devices market for the year 2017 due to the increased adoption of PCI procedures over conventional treatment methods; the non-invasive and safer approach of PCI mainly contributes to this shift. In addition, technological advancements in the nature and material of stents will make this segment grow at the fastest CAGR. Greater prices of stents and their incumbent role in the prevention of restenosis mainly drive the growth of this segment.

For the purpose of this study, the global market for percutaneous coronary intervention devices is studied for their application in the following usage areas:

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Catheterization Labs

Percutaneous coronary intervention (PCI) procedures are adopted across the world for the treatment of coronary heart disease. PCI is a minimally invasive procedure and thereby potentially reduces the risk of post-treatment complications and infections. In terms of market value, hospitals led the global percutaneous coronary intervention devices market for the year 2017 due to the availability of skilled professionals required for the PCI procedure.

Furthermore, the availability of favorable reimbursements in hospitals and devices that aid in minimally invasive techniques, such as robotic devices, favors the prominent position of the hospital segment. However, with the increase in the number of cases for PCI procedures, the population is turning towards catheterization labs for treatment due to the quick turnaround time.Based on geographical regions, the global percutaneous coronary intervention devices market is segmented into North America, Latin America, Asia Pacific, Europe, and the Middle East and Africa.

As per the research, North America dominated the global percutaneous coronary intervention devices market in 2017 and is projected to retain its lead in the market throughout the forecast period. The adoption of PCI procedures, improved healthcare services, and the high incidence of coronary artery disease in the region contribute to its dominance. The global percutaneous coronary intervention devices market in North America is expected to grow further due to supportive government initiatives and favorable reimbursement policies.

According to the CDC, coronary artery disease is the most common type of heart disease, killing over 370,000 individuals annually. Further, Asia Pacific is anticipated to experience the fastest market growth during the forecast years. This regional growth is anticipated due to the increasing prevalence of heart diseases, rising healthcare facilities, and increased awareness of heart diseases among the general population.

The detailed regional classification of the global percutaneous coronary intervention market is as follows:

  • North America
  • North American Percutaneous Coronary Intervention Devices Market, by Device Type, 2016–2026 (US$ Mn)
  • North American percutaneous coronary intervention devices market, by end-user, 2016–2026 (US$ Mn)
  • North America Percutaneous Coronary Intervention Devices Market, by Country, 2016–2026 (US$ Mn)
  • U.S.
  • Canada
  • Europe
  • Europe Percutaneous Coronary Intervention Devices Market, by Device Type, 2016–2026 (US$ Mn)
  • Europe Percutaneous Coronary Intervention Devices Market, by End-User, 2016–2026 (US$ Mn)
  • Europe Percutaneous Coronary Intervention Devices Market, by Country, 2016–2026 (US$ Mn)
  • U.K.
  • Germany
  • Rest of Europe
  • Asia Pacific
  • Asia Pacific Percutaneous Coronary Intervention Devices Market, by Device Type, 2016–2026 (US$ Mn)
  • Asia Pacific Percutaneous Coronary Intervention Devices Market, by End-User, 2016–2026 (US$ Mn)
  • Asia Pacific Percutaneous Coronary Intervention Devices Market, by Country, 2016–2026 (US$ Mn)
  • China
  • Japan
  • Rest of Asia Pacific
  • Latin America
  • Latin America Percutaneous Coronary Intervention Devices Market, by Device Type, 2016–2026 (US$ Mn)
  • Latin America Percutaneous Coronary Intervention Devices Market, by End-User, 2016–2026 (US$ Mn)
  • Latin America Percutaneous Coronary Intervention Devices Market, by Country, 2016–2026 (US$ Mn)
  • Brazil
  • Mexico
  • rest of Latin America
  • Middle East and Africa (MEA)
  • Middle East and Africa Percutaneous Coronary Intervention Devices Market, by Device Type, 2016–2026 (US$ Mn)
  • Middle East and Africa Percutaneous Coronary Intervention Devices Market, by End-User, 2016–2026 (US$ Mn)
  • Middle East and Africa Percutaneous Coronary Intervention Devices Market, by Country, 2016–2026 (US$ Mn)
  • GCC
  • Rest of the Middle East and Africa

Frequently Asked Questions:

The market for Percutaneous Coronary Intervention (PCI) Devices Market is expected to reach US$ 8.70 Bn by 2026.

The Percutaneous Coronary Intervention (PCI) Devices Market is expected to see significant CAGR growth over the coming years, at 4.3%.

The report is forecasted from 2018-2026.

The base year of this report is 2017.

Abbott Laboratories, Inc., Boston Scientific Corporation, Biotronik SE & Co. KG, B. Braun Melsungen AG, Biosensors International Group, Getinge AB, Johnson & Johnson, Medtronic plc, St. Jude Medical, and Terumo Corporation are some of the major players in the global market.

Choose License Type
Trusted By
Godaddy
Published Date:  Jan 2018
Category:  Medical Devices
Report ID:   58198
Report Format:   PDF
Pages:   120
Rating:    4.3 (50)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support